These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9024367)

  • 21. Hereditary hemochromatosis: a HpaI polymorphism within the HLA-H gene.
    Totaro A; Grifa A; Carella M; D'Ambrosio L; Valentino M; Roth MP; Borot N; Coppin H; Roetto A; Camaschella C; Gasparini P
    Mol Cell Probes; 1997 Jun; 11(3):229-30. PubMed ID: 9232622
    [No Abstract]   [Full Text] [Related]  

  • 22. Traffic jam for hemochromatosis mutant protein.
    Adams PC
    Hepatology; 1997 Dec; 26(6):1684-5. PubMed ID: 9398018
    [No Abstract]   [Full Text] [Related]  

  • 23. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 24. The significance of the 187G (H63D) mutation in hemochromatosis.
    Beutler E
    Am J Hum Genet; 1997 Sep; 61(3):762-4. PubMed ID: 9326341
    [No Abstract]   [Full Text] [Related]  

  • 25. Overestimation of HFE C282Y homozygous hemochromatosis prevalence as the result of a common primer-binding site polymorphism.
    Press RD
    Mol Diagn; 1999 Dec; 4(4):391-2. PubMed ID: 10671650
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutation analysis of the HLA-H gene in French hemochromatosis patients, and genetic counseling in families.
    Mercier G; Burckel A; Bathelier C; Boillat E; Lucotte G
    Genet Couns; 1998; 9(3):181-6. PubMed ID: 9777338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential HFE allele expression in hemochromatosis heterozygotes.
    Bergamaschi G; Rolandi V; Cazzola M
    Gastroenterology; 2001 Apr; 120(5):1308-9. PubMed ID: 11288747
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hereditary hemochromatosis: biochemical and genetic diagnosis].
    Quintero E
    Gastroenterol Hepatol; 1999 Feb; 22 Suppl 1():1-5. PubMed ID: 10085593
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA-H and associated proteins in patients with hemochromatosis.
    Beutler E; West C; Gelbart T
    Mol Med; 1997 Jun; 3(6):397-402. PubMed ID: 9234244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of HFE polymorphism in German patients with hereditary hemochromatosis].
    Burggraf S; Olgemöller B
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1346; author reply 1347. PubMed ID: 11109419
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
    Burt MJ; Upton JD; Morison IM; Chapman BA; Faed JM; George PM
    N Z Med J; 1997 Nov; 110(1056):429-32. PubMed ID: 9418837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis.
    Jeffrey GP; Chakrabarti S; Hegele RA; Adams PC
    Nat Genet; 1999 Aug; 22(4):325-6. PubMed ID: 10431233
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemochromatosis case detection by genetic testing: a new era.
    Kilpatrick ES; Jagger C
    Ann Clin Biochem; 1998 Sep; 35 ( Pt 5)():674-7. PubMed ID: 9768336
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 35. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England.
    Willis G; Jennings BA; Goodman E; Fellows IW; Wimperis JZ
    Blood Cells Mol Dis; 1997 Aug; 23(2):288-91. PubMed ID: 9410472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemochromatosis gene mutation in hepatocellular cancer.
    Willis G; Wimperis JZ; Lonsdale R; Jennings BA
    Lancet; 1997 Aug; 350(9077):565-6. PubMed ID: 9284787
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac hemochromatosis in an HFE His63Asp (187C->G) heterozygote.
    Winer D; Silversides C; Israel N; Rinne C; Chang WS; Butany J
    Can J Cardiol; 2004 Aug; 20(10):971-2. PubMed ID: 15332145
    [No Abstract]   [Full Text] [Related]  

  • 39. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
    Datz C; Lalloz MR; Vogel W; Graziadei I; Hackl F; Vautier G; Layton DM; Maier-Dobersberger T; Ferenci P; Penner E; Sandhofer F; Bomford A; Paulweber B
    J Hepatol; 1997 Nov; 27(5):773-9. PubMed ID: 9382962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hemochromatosis gene.
    Leber BF
    Clin Invest Med; 2000 Dec; 23(6):382-6. PubMed ID: 11152407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.